Literature DB >> 1454157

Grade II and grade III hypothyroidism in rapid-cycling bipolar patients.

M Kusalic1.   

Abstract

Thyroid function was evaluated in 10 rapid-cycling bipolar patients who had previously responded to lithium treatment. Five patients had grade II and 1 patient had grade III hypothyroidism as determined by thyrotropin-releasing hormone tests. Treatment with thyroxine in addition to lithium significantly decreased the intensity and frequency of rapid cycling episodes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1454157     DOI: 10.1159/000118833

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  6 in total

1.  Effect of lithium maintenance therapy on thyroid and parathyroid function.

Authors:  M Kusalic; F Engelsmann
Journal:  J Psychiatry Neurosci       Date:  1999-05       Impact factor: 6.186

2.  Adjunctive thyroid hormone treatment in rapid cycling bipolar disorder: A double-blind placebo-controlled trial of levothyroxine (L-T4 ) and triiodothyronine (T3 ).

Authors:  Patricia D Walshaw; Laszlo Gyulai; Michael Bauer; Mark S Bauer; Brian Calimlim; Catherine A Sugar; Peter C Whybrow
Journal:  Bipolar Disord       Date:  2018-06-04       Impact factor: 6.744

3.  Brain perfusion abnormalities in patients with euthyroid autoimmune thyroiditis.

Authors:  M Piga; A Serra; L Deiana; G L Loi; L Satta; M Di Liberto; S Mariotti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-31       Impact factor: 9.236

4.  Thyroid functions and bipolar affective disorder.

Authors:  Subho Chakrabarti
Journal:  J Thyroid Res       Date:  2011-07-26

5.  Psychiatric and clinical correlates of rapid cycling bipolar disorder: a cross-sectional study.

Authors:  Alexandre D Gigante; Ivan Y Barenboim; Rodrigo da S Dias; Ricardo A Toniolo; Tiago Mendonça; Ângela Miranda-Scippa; Flávio Kapczinski; Beny Lafer
Journal:  Braz J Psychiatry       Date:  2016-06-14       Impact factor: 2.697

6.  Rapid cycling bipolar disorder is associated with antithyroid antibodies, instead of thyroid dysfunction.

Authors:  Zhaoyu Gan; Xiuhua Wu; Zhongcheng Chen; Yingtao Liao; Yingdong Wu; Zimeng He; Zhihua Yang; Qi Zhang
Journal:  BMC Psychiatry       Date:  2019-12-02       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.